Atle Fund Management AB

Sector-focusedMomentum followerQuality / disciplined sizing

Total reported value

$309.7M

Reporting period: 2026-03-31 · Number of holdings: 39

Atle Fund Management AB disclosed 39 holdings in its latest 13F filing for the period ending 2026-03-31, with total reported value of $309.7M and a quarterly turnover rate of 32.2%.

Personality snowflake

Concentration: 14.46
Portfolio Stability: 32.16
Momentum/Contrarian: 100
Sector conviction: 100
Diversification: 78
Sizing Uniformity: 93.52

Recent moves

Trim ABBV
0.0%　-$14.3M
Trim LLY
+27.6%　-$6.6M
Trim NBIX
-5.4%　-$5.6M
Trim ISRG
+217.4%　-$3.2M
Trim TMO
-23.2%　-$2.9M
Add MRK
-82.7%　$2.3M

Holdings Map

New buyAddUnchangedTrim

Top 10 holdings by weight

Full holdings list this quarter

#	Ticker	Issuer	Asset Subclass	Weight	Weight Change	Shares Change
1	LLY	Eli Lilly & Co	Stock-Healthcare	8.67%	-2.00%	+27.59%
2	MRK	Merck & Co. INC.	Stock-Healthcare	7.40%	+0.83%	-82.71%
3	TMO	Thermo Fisher Scientific INC	Stock-Healthcare	4.67%	-0.86%	-23.16%
4	ONC	Beone Medicines Ltd-adr	Stock-Other	3.92%	—	+3.18%
5	JNJ	Johnson & Johnson	Stock-Healthcare	3.86%	+3.86%	NEW
6	BBIO	Bridgebio Pharma INC	Stock-Healthcare	3.84%	+0.39%	-21.18%
7	VRTX	Vertex Pharmaceuticals INC	Stock-Healthcare	3.61%	+0.29%	—
8	ABBV	Abbvie INC	Stock-Healthcare	3.35%	-4.54%	—
9	SYK	Stryker CORP	Stock-Healthcare	3.09%	+0.08%	—
10	ISRG	Intuitive Surgical INC	Stock-Healthcare	3.05%	-0.98%	+217.40%
11	IONS	Ionis Pharmaceuticals INC	Stock-Healthcare	3.03%	+0.70%	-69.83%
12	MIRM	Mirum Pharmaceuticals INC	Stock-Other	3.03%	+0.77%	+118.28%
13	CVS	Cvs Health CORP	Stock-Healthcare	2.99%	+0.29%	-77.68%
14	RVMD	Revolution Medicines INC	Stock-Healthcare	2.93%	+0.64%	+584.43%
15	BSX	Boston Scientific CORP	Stock-Healthcare	2.86%	-0.45%	-62.80%
16	AMGN	Amgen INC	Stock-Healthcare	2.81%	+0.52%	—
17	EW	Edwards Lifesciences CORP	Stock-Healthcare	2.67%	+2.67%	NEW
18	ALKS	Alkermes plc	Stock-Healthcare	2.66%	+0.50%	—
19	INCY	Incyte CORP	Stock-Healthcare	2.57%	+0.34%	-28.31%
20	NBIX	Neurocrine Biosciences INC	Stock-Healthcare	2.54%	-1.75%	-5.39%
21	GILD	Gilead Sciences INC	Stock-Healthcare	2.31%	+0.32%	-5.57%
22	KRYS	Krystal Biotech INC	Stock-Healthcare	2.19%	-0.47%	+11.01%
23	COR	Cencora INC	Stock-Healthcare	2.13%	-0.43%	-1.27%
24	IRTC	Irhythm Holdings INC	Stock-Healthcare	2.02%	-0.11%	-40.60%
25	INSM	Insmed INC	Stock-Healthcare	1.92%	+0.37%	+249.58%
26	NAMS	NewAmsterdam Pharma Company N.V.	Stock-Other	1.78%	-0.43%	-51.89%
27	CELC	Celcuity INC	Stock-Other	1.66%	+0.33%	+237.78%
28	ABVX	Abivax Sa-adr	Stock-Other	1.54%	+0.18%	—
29	CAH	Cardinal Health INC	Stock-Healthcare	1.54%	—	+363.07%
30	IDYA	Ideaya Biosciences INC	Stock-Other	1.30%	+0.23%	-68.05%
31	TNGX	Tango Therapeutics INC	Stock-Other	1.17%	+1.17%	NEW
32	SYRE	Spyre Therapeutics INC	Stock-Other	1.13%	+1.13%	NEW
33	IRON	Disc Medicine INC	Stock-Other	1.03%	-0.19%	+123.60%
34	CMPX	Compass Therapeutics INC	Stock-Other	0.99%	-0.01%	-92.84%
35	UNH	Unitedhealth Group INC	Stock-Healthcare	0.90%	-0.12%	—
36	DXCM	Dexcom INC	Stock-Healthcare	0.85%	+0.01%	+1371.05%
37	BCAX	Bicara Therapeutics INC	Stock-Other	0.75%	+0.15%	+950.29%
38	SLNOEUR	Soleno Therapeutics INC	Stock-Other	0.71%	-0.22%	+43.75%
39	PYXS	Pyxis Oncology INC	Stock-Other	0.52%	+0.29%	-68.08%

Portfolio Performance

Performance for Q3 2026

+14.9%

Performance Last 4 Quarters

+32%

Based on 55% of reported portfolio value with available pricing

Stdev: +14.9%
Beta: +0.54
Alpha: +1.3%
Max Drawdown: -16%
Annualized Perf: +10%
Batting Avg vs S&P: +42.4%
Sortino: +1.29
Stutzer: +0.21
Treynor: +0.2
Sterling: +0.54
Calmar: +0.63
Information Ratio: -0.47
Tracking Error: +14.5%
Stdev Down: +8.3%
Winning Months %: +51.5%
Losing Months %: +48.5%
Best 12 Months: +32%
Worst 12 Months: -13.5%
Efficiency Ratio: +0.25
Sharpe: +0.71
Stdev Sectors: 0%
Skewness: +0.14
Kurtosis: -0.75
Upside Potential: +3.27

Reported value over time

Sector allocation

Sector allocation over time

Quarterly history

Period	Holdings	Total value	Stability	Top holdings
2026-03-31	39	$309.7M	32	1LLY 2MRK 3TMO Top holdings2026-03-31 1.LLY 2.MRK 3.TMO 4.ONC 5.JNJ 6.BBIO 7.VRTX 8.ABBV 9.SYK 10.ISRG
2025-12-31	39	$313.4M	100	1LLY 2ABBV 3MRK Top holdings2025-12-31 1.LLY 2.ABBV 3.MRK 4.TMO 5.NBIX 6.ISRG 7.ONC 8.BBIO 9.VRTX 10.BSX
2025-09-30	38	$27.0M	100	1LLY 2ABBV 3NBIX Top holdings2025-09-30 1.LLY 2.ABBV 3.NBIX 4.MRK 5.TMO 6.ONC 7.BBIO 8.COR 9.ISRG 10.GILD
2025-06-30	37	$233.7M	0	1LLY 2ABBV 3BSX Top holdings2025-06-30 1.LLY 2.ABBV 3.BSX 4.NBIX 5.MRK 6.SYK 7.VRTX 8.ISRG 9.TMO 10.COR
2025-03-31	37	$226.5M	100	1LLY 2ABBV 3UNH Top holdings2025-03-31 1.LLY 2.ABBV 3.UNH 4.BSX 5.MRK 6.TMO 7.VRTX 8.COR 9.GILD 10.SYK
2024-12-31	36	$210.8M	0	1LLY 2UNH 3ABBV Top holdings2024-12-31 1.LLY 2.UNH 3.ABBV 4.BSX 5.TMO 6.MRK 7.SYK 8.NBIX 9.ALKS 10.VRTX
2024-09-30	36	$212.8M	0	1LLY 2UNH 3MRK Top holdings2024-09-30 1.LLY 2.UNH 3.MRK 4.TMO 5.AMGN 6.BSX 7.ABBV 8.SYK 9.COR 10.VRTX
2024-06-30	38	$164.0M	0	1LLY 2UNH 3MRK Top holdings2024-06-30 1.LLY 2.UNH 3.MRK 4.TMO 5.AMGN 6.BSX 7.REGN 8.VRTX 9.COR 10.SYK
2024-03-31	44	$164.4M	0	1MRK 2LLY 3UNH Top holdings2024-03-31 1.MRK 2.LLY 3.UNH 4.TMO 5.NBIX 6.HRMY 7.SYK 8.AMGN 9.ABBV 10.BSX
2023-12-31	45	$127.8M	0	1UNH 2LLY 3GILD Top holdings2023-12-31 1.UNH 2.LLY 3.GILD 4.COR 5.MRK 6.TMO 7.CAH 8.HRMY 9.AMGN 10.CNC
2022-12-31	53	$51.8M	0	1UTMD 2CAH 3CI Top holdings2022-12-31 1.UTMD 2.CAH 3.CI 4.VTRS 5.GSK 6.GILD 7.CVS 8.BMY 9.ZVRA 10.AUPH
2022-09-30	10	$47.3M	0	1UTMD 2BMY 3GILD Top holdings2022-09-30 1.UTMD 2.BMY 3.GILD 4.CI 5.ZVRA 6.CAH 7.MCK 8.VTRS 9.OPNTEUR 10.AUPH
2022-06-30	12	$43.4M	0	1UTMD 2LJPC 3HRMY Top holdings2022-06-30 1.UTMD 2.LJPC 3.HRMY 4.CI 5.GILD 6.BMY 7.BIIB 8.MCK 9.VTRS 10.ZVRA
2022-03-31	12	$62.8M	0	1MCK 2IRWD 3BMY Top holdings2022-03-31 1.MCK 2.IRWD 3.BMY 4.BIIB 5.HRMY 6.GILD 7.CI 8.CAH 9.UTMD 10.LJPC
2021-12-31	13	$71.0M	0	1IRWD 2MCK 3HRMY Top holdings2021-12-31 1.IRWD 2.MCK 3.HRMY 4.ABBV 5.CAH 6.COR 7.BMY 8.UTMD 9.LJPC 10.LN5
2021-09-30	17	$66.8M	0	1IRWD 2SUPN 3ARAY Top holdings2021-09-30 1.IRWD 2.SUPN 3.ARAY 4.HRMY 5.RIGLUSD 6.LN5 7.UTMD 8.ZGNXEUR 9.ALDX 10.EOLS
2021-06-30	9	$105.5M	100	1IRWD 2SUPN 3VRTX Top holdings2021-06-30 1.IRWD 2.SUPN 3.VRTX 4.ARAY 5.MCK 6.BMY 7.CI 8.CAH 9.ABBV
2021-03-31	15	$125.6M	69	1IRWD 2SUPN 3ARAY Top holdings2021-03-31 1.IRWD 2.SUPN 3.ARAY 4.CHRS 5.BDSIUSD 6.UTHR 7.VRTX 8.ABBV 9.UHS 10.COR
2020-12-31	17	$151.0M	100	1SUPN 2CHRS 3VTRS Top holdings2020-12-31 1.SUPN 2.CHRS 3.VTRS 4.CI 5.COLL 6.IRWD 7.UHS 8.ABBV 9.MCK 10.COR
2017-12-31	16	$47.4M	90	1ANIK 2CRL350540R Top holdings2017-12-31 1.ANIK 2.CRL 3.50540R 4.DGX 5.CAH 6.MCK 7.ELV 8.LGND 9.MDT 10.CI
2017-09-30	12	$85.6M	42	1MCK 2ELV 3ANIK Top holdings2017-09-30 1.MCK 2.ELV 3.ANIK 4.CI 5.CRL 6.LGND 7.PFE 8.WAT 9.BIIB 10.50540R
2017-06-30	11	$80.2M	93	1ELV 2MCK 3COR Top holdings2017-06-30 1.ELV 2.MCK 3.COR 4.CRL 5.50540R 6.GILD 7.PFE 8.LGND 9.BIIB 10.ANIK
2017-03-31	10	$65.2M	100	100817Y2COR 3GILD Top holdings2017-03-31 1.00817Y 2.COR 3.GILD 4.ANIK 5.CRL 6.MCK 7.68827R 8.GNCIQ 9.ACHNEUR 10.ICCC
2016-12-31	15	$108.5M	67	1SUPN 2ANIK 3CAH Top holdings2016-12-31 1.SUPN 2.ANIK 3.CAH 4.CRL 5.COR 6.M8737E 7.ELV 8.GILD 9.MRK 10.MCK
2016-09-30	15	$134.4M	68	1CAH 2COR 3ELV Top holdings2016-09-30 1.CAH 2.COR 3.ELV 4.SYNHEUR 5.CRL 6.GNCIQ 7.MRK 8.ANIK 9.GTS 10.M8737E
2016-06-30	18	$218.1M	42	1ANIK 2GNCIQ 3AMAG Top holdings2016-06-30 1.ANIK 2.GNCIQ 3.AMAG 4.SUPN 5.GTS 6.MRK 7.COR 8.30241L 9.M8737E 10.CAH
2016-03-31	18	$213.6M	70	1ANIK230241L3LTH Top holdings2016-03-31 1.ANIK 2.30241L 3.LTH 4.GNCIQ 5.AMAG 6.SUPN 7.CRL 8.M8737E 9.SYNHEUR 10.MRK
2015-12-31	14	$212.5M	63	1LTH 2GNCIQ 3GILD Top holdings2015-12-31 1.LTH 2.GNCIQ 3.GILD 4.AMAG 5.MGLNUSD 6.VAREUR 7.ELV 8.CRL 9.GTS 10.ANIK
2015-09-30	14	$169.1M	55	1GILD 2PFE 3LTH Top holdings2015-09-30 1.GILD 2.PFE 3.LTH 4.CRL 5.ELV 6.MGLNUSD 7.VAREUR 8.GTS 9.SUPN 10.ARLP
2015-06-30	14	$195.7M	48	1PFE 2GILD 3ELV Top holdings2015-06-30 1.PFE 2.GILD 3.ELV 4.00817Y 5.LTH 6.GTS 7.CRL 8.MGLNUSD 9.ARLP 10.87160G
2015-03-31	15	$144.4M	39	1MGLNUSD 2PFE 3ELV Top holdings2015-03-31 1.MGLNUSD 2.PFE 3.ELV 4.00817Y 5.LTH 6.GILD 7.602675 8.ARLP 9.CRL 10.GTS
2014-12-31	16	$121.0M	81	1PFE 2ARLP383066R Top holdings2014-12-31 1.PFE 2.ARLP 3.83066R 4.CRL 5.LTH 6.00817Y 7.ELV 8.MGLNUSD 9.602675 10.GILD
2014-09-30	16	$137.1M	34	100817Y294973V3ARLP Top holdings2014-09-30 1.00817Y 2.94973V 3.ARLP 4.885175 5.CAH 6.CRL 7.GILD 8.14170T 9.MGLNUSD 10.MDT
2014-06-30	19	$177.6M	32	194973V28851753MGLNUSD Top holdings2014-06-30 1.94973V 2.885175 3.MGLNUSD 4.CRL 5.ARLP 6.00817Y 7.LTH 8.MDT 9.HRC 10.GILD
2014-03-31	18	$140.3M	71	1CRL 2ARLP 3HO1 Top holdings2014-03-31 1.CRL 2.ARLP 3.HO1 4.MDT 5.94973V 6.HRC 7.LTH 8.14170T 9.MGLNUSD 10.00817Y
2013-12-31	18	$100.5M	—	1AXP 2CRL 3MDT Top holdings2013-12-31 1.AXP 2.CRL 3.MDT 4.MYGN 5.94973V 6.ARLP 7.LTH 8.HO1 9.MCK 10.HRC

Holding changes this quarter

Atle Fund Management AB's most significant position changes for 2026-03-31: New buy: Johnson & Johnson (JNJ); New buy: Edwards Lifesciences CORP (EW); Sold out: Ufp Technologies INC (UFPT); New buy: Tango Therapeutics INC (TNGX); New buy: Spyre Therapeutics INC (SYRE).

Position changes disclosed by Atle Fund Management AB for the quarter ending 2026-03-31, including ticker, issuer, weight change, shares change, and action
#	Ticker	Issuer	Weight Change	Shares Change	Action
1	MRK	Merck & Co. INC.	+0.8%	-82.71%	Trim
2	MIRM	Mirum Pharmaceuticals INC	+0.8%	+118.28%	Add
3	IONS	Ionis Pharmaceuticals INC	+0.7%	-69.83%	Trim
4	RVMD	Revolution Medicines INC	+0.6%	+584.43%	Add
5	AMGN	Amgen INC	+0.5%	—	Unchanged
6	ALKS	Alkermes plc	+0.5%	—	Unchanged
7	BBIO	Bridgebio Pharma INC	+0.4%	-21.18%	Trim
8	INSM	Insmed INC	+0.4%	+249.58%	Add
9	INCY	Incyte CORP	+0.3%	-28.31%	Trim
10	CELC	Celcuity INC	+0.3%	+237.78%	Add
11	GILD	Gilead Sciences INC	+0.3%	-5.57%	Trim
12	PYXS	Pyxis Oncology INC	+0.3%	-68.08%	Trim
13	CVS	Cvs Health CORP	+0.3%	-77.68%	Trim
14	VRTX	Vertex Pharmaceuticals INC	+0.3%	—	Unchanged
15	IDYA	Ideaya Biosciences INC	+0.2%	-68.05%	Trim
16	ABVX	Abivax Sa-adr	+0.2%	—	Unchanged
17	BCAX	Bicara Therapeutics INC	+0.2%	+950.29%	Add
18	SYK	Stryker CORP	+0.1%	—	Unchanged
19	DXCM	Dexcom INC	0%	+1371.05%	Add
20	ONC	Beone Medicines Ltd-adr	—	+3.18%	Add
21	CAH	Cardinal Health INC	—	+363.07%	Add
22	CMPX	Compass Therapeutics INC	0%	-92.84%	Trim
23	IRTC	Irhythm Holdings INC	-0.1%	-40.60%	Trim
24	UNH	Unitedhealth Group INC	-0.1%	—	Unchanged
25	IRON	Disc Medicine INC	-0.2%	+123.60%	Add
26	SLNOEUR	Soleno Therapeutics INC	-0.2%	+43.75%	Add
27	COR	Cencora INC	-0.4%	-1.27%	Trim
28	NAMS	NewAmsterdam Pharma Company N.V.	-0.4%	-51.89%	Trim
29	BSX	Boston Scientific CORP	-0.5%	-62.80%	Trim
30	KRYS	Krystal Biotech INC	-0.5%	+11.01%	Add
31	TMO	Thermo Fisher Scientific INC	-0.9%	-23.16%	Trim
32	ISRG	Intuitive Surgical INC	-1%	+217.40%	Add
33	NBIX	Neurocrine Biosciences INC	-1.8%	-5.39%	Trim
34	LLY	Eli Lilly & Co	-2%	+27.59%	Add
35	ABBV	Abbvie INC	-4.5%	—	Unchanged
36	JNJ	Johnson & Johnson	—	NEW	New buy
37	EW	Edwards Lifesciences CORP	—	NEW	New buy
38	UFPT	Ufp Technologies INC	—	EXIT	Sold out
39	TNGX	Tango Therapeutics INC	—	NEW	New buy
40	SYRE	Spyre Therapeutics INC	—	NEW	New buy
41	ACLXGBX	Arcellx INC	—	EXIT	Sold out
42	AUTL	Autolus Therapeutics PLC	—	EXIT	Sold out
43	CRBP	Corbus Pharmaceuticals Holdi	—	EXIT	Sold out

FAQ

What is Atle Fund Management AB and what type of investor is it?

Atle Fund Management AB is a investment manager that files SEC Form 13F quarterly, disclosing its U.S. public equity holdings to regulators. As of the most recent reporting period (2026-03-31), the firm manages a tracked equity portfolio valued at approximately $309.7M, spread across 39 disclosed positions.

What are Atle Fund Management AB's largest equity positions?

Based on the latest 13F filing, Atle Fund Management AB's top holdings by market value are: 1. Eli Lilly & Co (LLY) — $26.8M (8.7%) 2. Merck & Co. INC. (MRK) — $22.9M (7.4%) 3. Thermo Fisher Scientific INC (TMO) — $14.4M (4.7%) 4. Beone Medicines Ltd-adr (ONC) — $12.1M (3.9%) 5. Johnson & Johnson (JNJ) — $11.9M (3.9%)

What changes did Atle Fund Management AB make in its most recent portfolio filing?

In the latest reported quarter, Atle Fund Management AB made 36 notable position adjustments: 4 new positions were initiated, 13 existing holdings were added to, 15 positions were partially reduced, and 4 were completely exited. The largest of these moves: New buy: Johnson & Johnson (JNJ); New buy: Edwards Lifesciences CORP (EW); Sold out: Ufp Technologies INC (UFPT); New buy: Tango Therapeutics INC (TNGX); New buy: Spyre Therapeutics INC (SYRE)

What sectors does Atle Fund Management AB focus on?

Atle Fund Management AB is concentrated in the following sectors based on its current disclosed equity portfolio: • Health Care: 100.0%